John Beaudoin Sr & Kevin McKernan on Joseph Arthur & his Technicolor Dreamcast - 3 December 2023

On today's show, independent researchers and writers John Beaudoin Sr. and Kevin McKernan review Steve Kirsch's recent 'data bombshell' speech at MIT and take turns sharing their expert analysis of the pandemic and the subsequent jabs. John and Kevin each tell their remarkable stories of how they were able to recognize the scam of the pandemic early on, as a result of their respective fields of study. Also, John shares a profound and personal story, and Kevin explains some of his pioneering scientific work in the field of therapeutic cannabis.

GUEST 1 OVERVIEW: John Paul Beaudoin, Sr. is an American author and father of three men for whom he spent all of his meaningful life caring. John has a Master’s degree in Business Administration and a Bachelor’s degree in Computer & Systems Engineering. After more than thirty (>30) years developing and executing campaigns for contracts in the electronics and semiconductors research and development industry, John lost his eldest son at twenty (20) years old in a motorcycle accident. Two (2) years afterward, the covid era began. John simply wanted truth and could not find it in government data, media announcements, press releases, or local conversations. He sought a signal amongst the noise. John knew that things were not as we were programmed to believe. Having been in sales and marketing, he recognized the tactics used against the populace. Three (3) and four (4) word catch phrases were repeated ad nauseam on television and social media. This is programming, marketing, advertising, manipulation, propaganda. “Two weeks to flatten the curve” “Safe and effective” “I wear my mask for you” “Six feet” “Antivaxers are selfish” “Don’t kill grandma” “Correlation doesn’t equal causation” John recognizes these mass manipulation tactics and strategies because he sees first-hand the outcome of such manipulation. He sees the world from a viewpoint of interrelated systems. When orders were given to lock down, social distance, mask, or vaccinate, John knew immediately the negative externalities that would ensue. Some people are frail in physical and mental health. Stark societal changes will maim or kill those at the margins of health. Given John’s horizontal aptitude, he was a good fit for the problem. His insight is gleaned from his years of problem solving from an engineering point of view. This includes a unique and cursory knowledge across a wide range of disciplines including : psychology, sociology, economics, law, finance, accounting, physical sciences, electrical engineering. John is one of a handful of people with the record-level source data and the systems-level vision to pull it all together into a broad understanding of how this covid era came to be. https://substack.com/@coquindechien https://twitter.com/JohnBeaudoinSr

GUEST 2 OVERVIEW: Kevin McKernan is the CSO and Founder of Medicinal Genomics and has pioneered the genomics of cannabis and hemp to build a stronger scientific environment (Kannapedia.net) for the study of cannabis based therapeutics and blockchain technologies for tracking and verifying cannabis genetics. Previously, Kevin was the CSO of Courtagen Life Sciences, Inc., and was Vice President and Director of R&D of Life Technologies where he managed the development of Life Technologies next generation SOLiD sequencing technology. Integral to the SOLiD R&D process, Kevin oversaw over 100 research collaborations exploring the new biological frontiers with next generation sequencing and saw particular excitement and traction in human tumor sequencing. Kevin initiated an R&D project to investigate chemFET semiconductor based DNA sequencing and spearheaded a process to acquire the DNA sequencing company Ion Torrent for $350M. These collaborations resulted in hundreds of publications and 7 Journal covers from Science Translational Medicine to Nature. Kevin was the President and CSO of Agencourt Personal Genomics, a startup company he co-founded in 2005 to invent revolutionary sequencing technologies that dropped the cost of sequencing a human genome from $300M to $3,000; a 100,000-fold improvement in sequencing speed and cost in a few years. In 2000, Kevin Co-Founded Agencourt Biosciences Corporation and acted as the CSO until it was acquired by Beckman Coulter. Kevin also managed the R&D for the Human Genome Project at Whitehead Institute/MIT resulting in several patents for nucleic acid purification. Kevin holds a B.S. in Biology from Emory University with a focus on cloning and expressing Norepinephrine Transporters. When not decoding DNA and unraveling the mysteries of cannabis medicine, Kevin enjoy boating, skiing, and gardening. https://substack.com/@kevinmckernan https://twitter.com/Kevin_McKernan